High-flow nasal therapy (HFNT) was introduced into clinical practice in the early 2000s as a form of noninvasive respiratory support (NIRS). During the last 20 years, a growing body of evidence has shown the value of this intervention in the management of acute and chronic respiratory failure.
Crimi, C., Cortegiani, A. (2023). High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future. JOURNAL OF CLINICAL MEDICINE, 12(7) [10.3390/jcm12072666].
High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future
Cortegiani, Andrea
2023-04-03
Abstract
High-flow nasal therapy (HFNT) was introduced into clinical practice in the early 2000s as a form of noninvasive respiratory support (NIRS). During the last 20 years, a growing body of evidence has shown the value of this intervention in the management of acute and chronic respiratory failure.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
jcm-12-02666 (1).pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
199.02 kB
Formato
Adobe PDF
|
199.02 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
